449
Views
37
CrossRef citations to date
0
Altmetric
Original Article

The evolution of botulinum neurotoxin type A for cosmetic applications

&
Pages 186-192 | Received 22 Apr 2007, Accepted 23 Apr 2007, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Maria Angelo-Khattar. (2020) A Novel OnabotulinumtoxinA Treatment Technique to Obtain Predictable Outcomes in Eyebrow Position and Shape. Clinical, Cosmetic and Investigational Dermatology 13, pages 781-787.
Read now
Ahmed Shafik Elridy, Rania Gamal Eldin Zaki & Reham Fawzy Elshinawy. (2018) Comparison of the Clinical Efficacy of Abobotulinumtoxin A (ABO) and Onabotulinumtoxin A (ONA) in the Treatment of Crow’s Feet Wrinkles: A Split-Face Study. Seminars in Ophthalmology 33:6, pages 739-747.
Read now

Articles from other publishers (34)

Nazanin Shabani Ravari, Maryam Ghareh Sheikhlou, Navid Goodarzi, Bahar Kharazian, Mohsen Amini, Fatemeh Atyabi, Saman A. Nasrollahi & Rassoul Dinarvand. (2023) Fabrication, characterization and evaluation of a new designed botulinum toxin-cell penetrating peptide nanoparticulate complex. DARU Journal of Pharmaceutical Sciences 31:1, pages 1-12.
Crossref
Jennifer A. Locke, Helia Nabavian, Sarah Neu, Sender Herschorn & Lesley K. Carr. (2021) Systemic muscular weakness after botulinum toxin A administration: a review of the literature. Drugs & Therapy Perspectives 37:7, pages 315-327.
Crossref
V.Yu. Avtomonov & E.A. Razumovskaya. (2021) Botulinum toxins in cosmetology: clarifications. Klinicheskaya dermatologiya i venerologiya 20:4, pages 135.
Crossref
Patrick M. Zito & Brad P. Glick. (2020) Complications of neurotoxins used in cosmetic surgery. Dermatological Reviews 1:2, pages 58-62.
Crossref
Je-Young Park, Owen Sunga, Rungsima Wanitphakdeedecha & Jürgen Frevert. (2020) Neurotoxin Impurities: A Review of Threats to Efficacy. Plastic and Reconstructive Surgery - Global Open 8:1, pages e2627.
Crossref
Hui-Pin Cheng & Han-Sheng Chuang. (2019) Rapid and Sensitive Nano-Immunosensors for Botulinum. ACS Sensors 4:7, pages 1754-1760.
Crossref
Daniel J. Ozzello & Joseph N. Giacometti. (2018) Botulinum Toxins for Treating Essential Blepharospasm and Hemifacial Spasm. International Ophthalmology Clinics 58:1, pages 49-61.
Crossref
Lyndsay L. Madden & Clark A. Rosen. 2018. Neurolaryngology. Neurolaryngology 109 123 .
Ryan M. Greene, John P. Arkins & Steven H. Dayan. 2017. Botulinum Toxins. Botulinum Toxins 121 131 .
Jason J. Emer, Eileen Axibal, Ellen S. Marmur & Heidi Waldorf. 2017. Botulinum Toxins. Botulinum Toxins 357 368 .
Donna Bilu Martin & Stephen Mandy. 2017. Botulinum Toxins. Botulinum Toxins 329 343 .
Alastair Carruthers & Jean Carruthers. 2017. Botulinum Toxins. Botulinum Toxins 1 12 .
Zhenhua Jia, Haibin Lu, Xiaonan Yang, Xiaolei Jin, Rongwei Wu, Jingyi Zhao, Lulu Chen & Zuoliang Qi. (2016) Adverse Events of Botulinum Toxin Type A in Facial Rejuvenation: A Systematic Review and Meta-Analysis. Aesthetic Plastic Surgery 40:5, pages 769-777.
Crossref
Anna Baker. (2016) Aesthetic applications for botulinum toxin type A: treating the upper and lower face. Journal of Aesthetic Nursing 5:7, pages 330-336.
Crossref
D. Hartmann, M. Heppt & G.G. Gauglitz. (2015) Nebenwirkungen von ästhetischen Behandlungen und deren VorbeugungManagement and prevention of adverse events in esthetic interventions. Der Hautarzt 66:10, pages 764-771.
Crossref
B. Molina, Y. Grangier, B. Mole, N. Ribe, L. Martín Diaz, W. Prager, F. Paliargues & N. Kerrouche. (2014) Patient satisfaction after the treatment of glabellar lines with Botulinum toxin type A (Speywood Unit): a multi‐centre European observational study. Journal of the European Academy of Dermatology and Venereology 29:7, pages 1382-1388.
Crossref
Kenneth D. Steinsapir, Michael J. Groth & Cynthia A. Boxrud. (2015) Persistence of Upper Blepharoptosis After Cosmetic Botulinum Toxin Type A. Dermatologic Surgery 41:7, pages 833-840.
Crossref
Mariana Figueiroa Careta, Livia Delgado & Régia Patriota. (2015) Report of Allergic Reaction After Application of Botulinum Toxin. Aesthetic Surgery Journal 35:5, pages NP102-NP105.
Crossref
Amy Hellman & Diego Torres-Russotto. (2014) Botulinum toxin in the management of blepharospasm: current evidence and recent developments. Therapeutic Advances in Neurological Disorders 8:2, pages 82-91.
Crossref
Jane Lee, Phil Kennedy & Jacob M. Waugh. 2015. Cell-Penetrating Peptides. Cell-Penetrating Peptides 397 415 .
Anne Han, Anna L. Chien & Sewon Kang. (2014) Photoaging. Dermatologic Clinics 32:3, pages 291-299.
Crossref
W.G. Philipp-Dormston. (2014) Botulinumtoxin in der DermatologieBotulinum toxin in dermatology. Humanmedizin kompakt.
Crossref
Wolfgang G. Philipp-Dormston. (2014) Botulinumtoxin in der Dermatologie. ästhetische dermatologie & kosmetologie 6:2, pages 24-34.
Crossref
W.G. Philipp-Dormston. (2014) Botulinumtoxin in der DermatologieBotulinum toxin in dermatology. Der Hautarzt 65:2, pages 133-145.
Crossref
Andrew Dorizas, Nils Krueger & Neil S. Sadick. (2014) Aesthetic Uses of the Botulinum Toxin. Dermatologic Clinics 32:1, pages 23-36.
Crossref
D.H. Lee, S.M. Kang, A. Feneran, C.S. Youn, J.K. Kim, S. Cho, C.H. Won, S.E. Chang, M.W. Lee, J.H. Choi & K.C. Moon. (2013) RimabotulinumtoxinB vs. onabotulinumtoxinA for the treatment of forehead lines: an evaluator-blind, randomized, pilot study. Journal of the European Academy of Dermatology and Venereology 27:1, pages e1-e7.
Crossref
Timothy Corcoran Flynn. (2012) Advances in the use of botulinum neurotoxins in facial esthetics. Journal of Cosmetic Dermatology 11:1, pages 42-50.
Crossref
Jacob M. Waugh, Jane Lee, Michael D. Dake & Dan Browne. 2011. Cell-Penetrating Peptides. Cell-Penetrating Peptides 553 572 .
Jean Carruthers & Alastair Carruthers. (2010) Botulinum Toxin in Facial Rejuvenation: An Update. Obstetrics and Gynecology Clinics of North America 37:4, pages 571-582.
Crossref
O.W. Majid. (2010) Clinical use of botulinum toxins in oral and maxillofacial surgery. International Journal of Oral and Maxillofacial Surgery 39:3, pages 197-207.
Crossref
David Beynet, Derek H. Jones & Timothy Corcoran Flynn. 2010. Facial Resurfacing. Facial Resurfacing 120 137 .
B Rzany, B Ascher & GD Monheit. (2010) Treatment of glabellar lines with botulinum toxin type A (Speywood Unit): a clinical overview. Journal of the European Academy of Dermatology and Venereology 24, pages 1-14.
Crossref
Jean Carruthers & Alastair Carruthers. (2009) Botulinum Toxin in Facial Rejuvenation: An Update. Dermatologic Clinics 27:4, pages 417-425.
Crossref
V. Gassia & T. Michaud. (2009) Les techniques d’injection du haut du visage : front et glabelle, pattes d’oie, région péri-oculaire. Annales de Dermatologie et de Vénéréologie 136, pages S104-S110.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.